Le Lézard
Classified in: Health, Science and technology
Subject: MRR

Clinical Data Management Systems Market worth USD 5.4 billion by 2030, says Global Market Insights Inc.

Prominent players operating in the Clinical Data Management Systems (CDMS) industry are Oracle Corporation, eClinical Solution LLC, IBM Corporation, CIMS, Axiom Real-Time Metrics, Medidata Solution (Dassault Systemes)., Fortress Medical, Veeva Systems, OpenClinica LLC, and Ennov.

SELBYVILLE, Del., July 7, 2022 /PRNewswire/ -- The clinical data management systems market value is projected to reach USD 5.4 billion by 2030 according to a new research report by Global Market Insights Inc.

Clinical Data Management Systems (CDMS) Market

Pharmaceutical and biopharmaceutical industry has one of the highest R&D expenses worldwide. Therefore, this will encourage various biopharma & pharma companies to outsource clinical trials services, thereby increasing the adoption rate. Furthermore, the clinical trials that companies opt to outsource include extensive research and tasks. Thus, to manage overall process of clinical trials, various companies opt for software solution including clinical data management solution to manage the large volume data, thereby augmenting the market expansion.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3131

Licensed enterprise solution segment surpassed USD 207.1 million in 2021. The licensed enterprise based CDMS also known as on demand CDMS are designed by a third party or a company to be licensed or sold to pharmaceutical and biotech firms. Licensed enterprise software is created considering all regulatory guidelines and are validated. Some CDMS tools like Oracle Clinical and Clintrial are of industry standards. These systems are not compatible for new component/module addition. However, these are preferred choice by industry players due to standardization, testing against set modules and validation.

Some major findings of the clinical data management systems market report include:

Browse key industry insights spread across 115 pages with 113 market data tables & 14 figures & charts from the report, "Clinical Data Management Systems Market Analysis By Delivery Mode (Licensed Enterprise Solutions, Cloud-based Solutions, Web-hosted Solutions), End-use (Contract Research Organizations, Medical Device Companies, Pharma/Biotech Companies), Industry Analysis Report, Regional Outlook , Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 ? 2030" in detail along with the table of contents:


Clinical data management systems market from medical device companies segment accounted for 16.1% revenue proportion in 2021 and is projected to witness considerable CAGR during the forecast timeframe. The medical device companies are in continuously inventions of novel medical devices and diagnostic tools for which they keep conducting medical device and diagnostic trials. The CDMS enables to manage data for the entire device and diagnostic development lifecycle. It helps reduce study time and conduct cost effective study with real time data reporting. Also, it can be useful to conduct multicentered studies and capture data from various sources.

Asia-Pacific clinical data management systems market is estimated to show robust CAGR of 13.8% during the forecast period. With need for effective clinical data and process management tools, the market will foresee immense growth opportunities in Asia Pacific region. Huge patient population, emergence of severe diseases, increasing clinical trials and R&D are some of regional growth driving factors. Also, there are several observational and post marketing surveillance studies going on continuously in the region especially Southeast Asian countries which is expected to boost the demand for such software.

A few notable companies operating in the clinical data management systems market include Oracle Corporation, eClinical Solution LLC, IBM Corporation, CIMS, Axiom Real-Time Metrics, Medidata Solution (Dassault Systemes)., Fortress Medical, Veeva Systems, OpenClinica LLC, Ennov, among others.

Request for customization of this research report @ https://www.gminsights.com/roc/3131

About Global Market Insights

Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com 

Global Market Insights Inc. Logo

Photo: https://mma.prnewswire.com/media/1855079/CDMS_Market.jpg
Logo: https://mma.prnewswire.com/media/661916/GMI.jpg 

These press releases may also interest you

at 18:31
OPSEU/SEFPO leaders have vowed that the tens of thousands of health care workers in their membership will fight health care privatization every step of the way. "We are appalled that in their second week back in the legislature, this is the Ford...

at 18:20
Biovancia, creator of Neo-Collagen and Artimium 360, warns consumers of the diminishing nutritional value of food consumed in the United States (as reported in "Still No Free Lunch: Nutrient levels in U.S. food supply eroded by pursuit of high...

at 18:17
Clinovo, a technology focused Clinical services provider that accelerates Clinical Development for Life Sciences industry appoints Nandish Poluru as Chief Executive Officer effective immediately. As an executive at the intersection of Lifesciences,...

at 17:53
HAVN Life Sciences Inc.  (the "Company" or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it has closed the initial tranche...

at 17:47
Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today announced that results from the Phase 3 BEACON study in Retinal...

at 17:34
The Registered Nurses' Association of Ontario (RNAO) says the government's five-point plan to tackle health system challenges represents an important building block to begin tackling critical issues facing the nursing profession. It should be...

News published on 7 july 2022 at 05:15 and distributed by: